Advanced surgical pathology device

Ended Project Grant Awarded Last action

Award ID
R43CA235915
Recipient
Awarding agency
Obligated
$877,500

Award facts

Assistance listing
93.393 Cancer Cause and Prevention Research
Completion date
Originally
Funding
  • $685,000.00 Federal
  • $192,500.00 Non-federal
Place of performance
New York, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $192,500 $0
Amendment Advanced surgical pathology device - each year, millions of americans are diagnosed with skin cancer. The treatment with the highest cure rate and best… $192,500 $192,500
Original award $300,000 $0

Quick answers

Who received award R43CA235915?

R43CA235915 was awarded to Surgivance Inc. by National Cancer Institute (National Institutes of Health) on August 1, 2019.

How much is award R43CA235915 worth?

$877,500 has been obligated on R43CA235915: $685,000 in federal funding and $192,500 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award